Acer Therapeutics Inc.
Focused on the acquisition, development & commercialization of therapies for serious rare and life-threatening disease.
16 employees · est. 2013 · Newton, United States
Optinose is the older company (2013 vs 2010); Optinose is the larger of the two.
Side-by-Side Comparison
| Metric | Acer Therapeutics Inc. | Optinose |
|---|---|---|
| Founded | ||
| Founded | 2013 | 2010 older |
| Headquarters | ||
| Headquarters | Newton, United States | Yardley, United States |
| Employees | ||
| Employees | 16 | 146 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biotechnology, Medical Devices, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $116.95M | $566.20M |
| Funding Rounds | ||
| Funding Rounds | 7 | 10 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Pharmaceutical Company, Rare Diseases, Drug Development, Therapeutic Acquisition, Commercialization, Infectious Diseases, COVID-19 Treatment, Vascular Ehlers-Danlos Syndrome, FDA Procedures, Management Team, Clinical Proof-of-concept Data, Company Culture, Employee Talent, Patient-centric Approach | Pharmaceutical Industry, ENT Specialists, Chronic Rhinosinusitis, Nasal Polyps, FDA Approval, Exhalation Delivery System, Clinical Trials, SNDA Submission, Drug Therapy, Employee Management, Company Culture |
| Website | ||
| Website | acertx.com | optinose.com |
About Acer Therapeutics Inc.
Acer Therapeutics Inc. is a biotechnology and pharmaceutical company founded in 2013 with the slogan "Focused on the acquisition, development & commercialization of therapies for serious rare and life-threatening diseases." The company is based in the United States. Acer's pipeline consists of four...
About Optinose
Optinose is a specialty pharmaceutical company focusing on the development and commercialization of products for patients treated by ear, nose, and throat (ENT) and allergy specialists. Its flagship product, XHANCE®, uses a proprietary Exhalation Delivery System™ (EDS®) to deliver a corticosteroid f...
We will tell you when either one moves
BounceWatch watches Acer Therapeutics Inc. and Optinose for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Acer Therapeutics Inc. and Optinose — by email.
Frequently Asked Questions
Compare Acer Therapeutics Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Acer Therapeutics Inc. on 12 Sep 2024, and Optinose on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
